These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19644471

  • 1. Pharmaceutical R&D: the road to positive returns.
    David E, Tramontin T, Zemmel R.
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract] [Full Text] [Related]

  • 2. R&D productivity rides again?
    Lendrem D, Senn SJ, Lendrem BC, Isaacs JD.
    Pharm Stat; 2015 Aug; 14(1):1-3. PubMed ID: 25336017
    [Abstract] [Full Text] [Related]

  • 3. Drug discovery: are productivity metrics inhibiting motivation and creativity?
    Ullman F, Boutellier R.
    Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910
    [Abstract] [Full Text] [Related]

  • 4. How should we support pharmaceutical innovation?
    Grootendorst P.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [Abstract] [Full Text] [Related]

  • 5. Escaping the pincer.
    Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ.
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [Abstract] [Full Text] [Related]

  • 9. Payers growing influence on R&D decision making.
    Hughes B.
    Nat Rev Drug Discov; 2008 Nov; 7(11):876-8. PubMed ID: 18974741
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. GAO report says drug R & D costs rising, innovation decreasing.
    Consult Pharm; 2007 Mar; 22(3):257-8. PubMed ID: 17691159
    [No Abstract] [Full Text] [Related]

  • 13. Innovative drug R&D in China.
    Qi J, Wang Q, Yu Z, Chen X, Wang F.
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract] [Full Text] [Related]

  • 14. Drug life-cycle technologies.
    Fleming E, Ma P.
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract] [Full Text] [Related]

  • 15. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D, Tear S.
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract] [Full Text] [Related]

  • 16. Discontinued drugs in 2010: oncology drugs.
    Williams R.
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [Abstract] [Full Text] [Related]

  • 17. An assessment of R&D productivity in the pharmaceutical industry.
    Dimitri N.
    Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
    [Abstract] [Full Text] [Related]

  • 18. Pharmaceutical sciences in 2020.
    Crommelin D, Stolk P, Besançon L, Shah V, Midha K, Leufkens H.
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract] [Full Text] [Related]

  • 19. Research and development productivity map: visualization of industry status.
    Shimura H, Masuda S, Kimura H.
    J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
    [Abstract] [Full Text] [Related]

  • 20. Growing against the grain.
    Boyle M.
    Fortune; 2004 May 03; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.